SchoenikeSE, DanaWJ. Ifosfamide and mesna. Clin Pharm1990;9:179-91.
2.
AtkinsonK, BiggsJ, NobleG, AshbyM, ConcannonA, DoddsA.Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. Bone Marrow Transplant1987;2:385-94.
ArthurRR, ShahKV, BaustSJ, SantosGW, SaralR.Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med1986;315:230-4.
5.
DeVriesCR, FreihaFS. Hemorrhagic cystitis: a review. J Urol1990;143:1-9.
TutschkaPJ, CopelanEA, KleinJP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood1987;70:1382-8.
8.
AtkinsonK, BiggsJC, GolovskyD, ConcannonA, DoddsA, DownsK. Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. Bone Marrow Transplant1991;7:351-4.
9.
HowsJM, MehtaA, WardL, WoodsK, PerezR, GordonMY. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Br J Cancer1984;50:753-6.
10.
ShepherdJD, PringleLE, BarnettMJ, KlingermannHG, ReeceDE, PhillipsGL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol1991;9: 2016-20.
11.
VoseJM, ReedEC, PippertGC, AndersonJR, BiermanPJ, KessingerA. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol1993;11:1306-10.
12.
DrollerMJ, SaralR, SantosG.Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology1982;20:256-8.
BrockN, PohlJ, StekarJ.Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. I. Eur J Cancer1981;17:595-607.
15.
SladekNE, SmithPC, BlattPM, LowJE, PowersJF, BorchRF. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity. Cancer Treat Rep1982;66:1889-900.
16.
ShawIC, GrahamMI. Mesna—-a short review. Cancer Treat Rev1987;14:67-86.
17.
LinkH, NeefV, NiethammerD, WilmsK.Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation (letter). Blut1981;43:329-30.
18.
BlacklockH, BallL, KnightC, ScheyS, PrenticeG.Experience with mesna in patients receiving allogeneic bone marrow transplants for poor prognostic leukaemia. Cancer Treat Rev1983;10(suppl A):45-52.
19.
NicolauDP, HoganKR. National survey of use of mesna for the prevention of cyclophosphamide-induced hemorrhagic cystitis in recipients of bone marrow transplants. Mayo Clin Proc1992;67:611-2.
20.
ChamplinRE, HorowitzMM, Van BekkumDW, CamillaBM, ElfenbeinGE, GaleRP. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood1989;73:606-13.
21.
LetendreL, HoaglandHC, GertzMA. Hemorrhagic cystitis complicating bone marrow transplantation. Mayo Clin Proc1992;67:128-30.